Tools
Holmes Tremor
Introduction
Holmes tremor is a rare, disabling movement disorder characterized by a combination of resting, postural, and intention tremor with low frequency (<4.5 Hz) and high amplitude.[1] Structural lesions affecting interconnected motor pathways, including cerebellothalamic and dopaminergic circuits, most commonly underlie the condition following stroke, trauma, tumor, or demyelinating disease. Onset is often delayed, developing weeks to months after the inciting injury, contributing to diagnostic challenges in clinical practice.
Prompt recognition of Holmes tremor is important due to its substantial impact on functional ability and quality of life, as well as frequent misclassification as other tremor disorders.[2] Accurate diagnosis requires careful clinical assessment and neuroimaging to identify underlying structural lesions. Management remains challenging, with pharmacologic therapies showing variable benefit and deep brain stimulation (DBS) reserved for refractory cases.
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Holmes tremor results from structural lesions disrupting interconnected motor pathways involving the cerebellum, thalamus, basal ganglia, and brainstem. Vascular events, including ischemic or hemorrhagic stroke, most commonly give rise to these lesions, although traumatic brain injury, tumors, demyelinating diseases such as multiple sclerosis, infections, and other inflammatory processes, such as neurosarcoidosis and autoimmune encephalitis, may also serve as etiologies. Vascular malformations, including cavernomas and arteriovenous malformations, have also been implicated.
Pathogenesis is thought to require involvement of multiple neural circuits, particularly the dopaminergic nigrostriatal system and cerebellothalamic pathways. A “multihit” mechanism helps explain the characteristic combination of resting, postural, and intention tremor. Delayed symptom onset, often weeks to months after the initial insult, likely reflects evolving neuronal dysfunction and maladaptive reorganization within motor networks.
Epidemiology
Holmes tremor is rare, and the available literature consists largely of case reports and small case series. Underrecognition and misclassification as other tremor syndromes may contribute to the limited number of reported cases. Misdiagnosis as another tremor disorder and failure to publish isolated cases may further contribute to underreporting. Raina et al identified only 155 reported cases in the literature from the original 1904 description through 2016.[3] This limited number of reported cases highlights the rarity of Holmes tremor.
The mean age at diagnosis was 30.6 years in a series of 20 patients, with a range of 8 to 64 years and a female-to-male ratio of 2:1. The median interval between lesion occurrence and tremor onset was 3.6 months, with a range of 1 month to 2 years. Another series of 23 patients reported a median interval of 29 days between lesion occurrence and tremor onset, with a range of 2 days to 20 months.[4]
Pathophysiology
Neuroimaging techniques have helped elucidate the pathophysiology of many tremor disorders.[5] In Holmes tremor, lesion-network mapping has identified lesions within a commonly connected brain circuit involving the cerebellum (vermis, lateral cerebellar cortex, and flocculonodular regions), globus pallidus pars internus (GPi), thalamus (ventralis oralis posterior or VOP; and pulvinar nuclei), red nucleus, and pontomedullary junction.[6][7] Several neural circuits have been associated with Holmes tremor, including the dopaminergic nigrostriatal system, dentatorubro-olivary pathways, and the cerebellothalamic system. Holmes tremor has been proposed to require disruption of more than 1 motor pathway, particularly the dopaminergic nigrostriatal system, in combination with cerebellothalamic or dentatorubro-olivary pathways.[8][9][10][11]
Involvement of the GPi and VOP suggests participation of a pallidal-thalamic circuit.[12][13] Involvement of the pulvinar nucleus suggests a role for posterior thalamic lesions in tremor generation.[14][15] The characteristic combination of resting, intention, and postural tremor likely reflects involvement of multiple neural regions and motor circuits.
The GPi influences the pedunculopontine nucleus through the descending reticulospinal tract, contributing to postural control through actions on axial and proximal appendicular musculature.[16] Thalamostriatal connections facilitate interactions between basal ganglia and cerebellar pathways, making the GPi a potential therapeutic target.[17][18][19]
Most causative injuries are irreversible. However, reversible cases of Holmes tremor have been reported following resolution of spontaneous intracranial hypotension or nonketotic hyperglycemia.[20][21] Midbrain distortion and swelling can produce functional disruption of interconnected brain circuits.
History and Physical
Tremor diagnosis is based on careful clinical examination, neurophysiologic studies, and radiologic assessment. Neurologic examination typically demonstrates a low-frequency, high-amplitude tremor with resting, postural, and intention components. Tremor most commonly affects a single limb or one side of the body and is often more prominent proximally than distally. Amplitude is typically greatest at rest and may increase during intentional movement. Frequency is generally less than 4.5 Hz. Prolonged or sustained posture often accentuates the tremor. The Fahn-Tolosa-Marin Tremor Rating Scale is used to assess tremor severity.[22] Pretreatment scores provide a baseline for evaluating response to medical or surgical intervention when posttreatment changes are observed.
Evaluation
Laboratory studies are usually nondiagnostic. Electromyography may be used to measure tremor frequency. Head computed tomography is useful in acute presentations when hemorrhage or other emergent structural pathology is suspected. Brain magnetic resonance imaging, with and without contrast when clinically indicated, is the preferred imaging modality for identifying ischemic, hemorrhagic, demyelinating, inflammatory, traumatic, neoplastic, or vascular lesions associated with Holmes tremor.
Treatment / Management
Medical Therapies
The most commonly used medications include levetiracetam, trihexyphenidyl, levodopa, dopamine agonists, and topiramate.[23][24] Reported responses to pharmacologic therapy are variable. However, levodopa, levetiracetam, dopamine agonists, topiramate, and anticholinergics, such as trihexyphenidyl, have been associated with clinical improvement in selected cases. Levetiracetam and trihexyphenidyl have demonstrated favorable responses in several reports. In the 2016 series by Raina et al, levodopa was effective in 13 of 24 treated patients, corresponding to a response rate of approximately 54%.[25] Second-line therapies that may provide symptomatic benefit include clonazepam, bromocriptine, amantadine, and biperiden, as well as botulinum toxin injections.[26](B2)
Surgical Interventions
Stereotactic lesioning procedures, including radiofrequency and thermal ablation, have produced partial improvement, particularly when targeting the thalamus.[27][28] Clinical benefit may diminish over time.[29] Gamma knife thalamotomy targeting the ventral intermediate (Vim) nucleus has also demonstrated partial benefit. A reported approach used a dose of 130 Gy prescribed to the 100% isodose line, with the 30% isodose line maintained lateral to the medial margin of the internal capsule.[30](B3)
Classical DBS targets within the Vim have produced a favorable clinical response, although only 31% of patients with Holmes tremor achieved substantial improvement.[31] The GPi and VOP have also been proposed as DBS targets based on the neural circuits implicated in Holmes tremor. Targets located slightly medial to the conventional GPi target have demonstrated favorable outcomes. DBS of the Vim and GPi provided better tremor suppression than medical therapy in 57.8% and 32.8% of patients, respectively.(B2)
GPi stimulation provides greater control of the resting tremor component and overall tremor severity. Greater efficacy of GPi stimulation than thalamic stimulation has been proposed in the presence of midbrain lesions. Postural tremor demonstrates the greatest surgical improvement, whereas outcomes for resting and intention tremor are comparable. GPi stimulation is associated with greater improvement in proximal tremor, whereas Vim stimulation provides better symptom control in distal tremor. Clinical benefit has been sustained during long-term follow-up. Planned targets cannot be used in some cases because of extensive involvement by the underlying lesion.[32]
Other DBS targets have demonstrated improvement in single cases, including the prelemniscal radiations (inferior to the caudal zona incerta) and the posterior subthalamic area (reported in 3 patients).[33][34] Stimulation of the ventralis oralis anterior (VOA) and VOP nuclei has also produced sustained improvement. Additional reported targets include the zona incerta, lenticular fasciculus, and subthalamic nucleus, with unilateral or bilateral stimulation producing variable degrees of benefit.[35]
Dual-target DBS strategies have been considered given involvement of multiple structures.[36] However, other studies have not demonstrated consistent benefit with multitarget approaches. In a patient with midbrain hemorrhage treated with Vim, GPi, and VOA stimulation, tremor improvement occurred only with GPi stimulation, while other targets did not provide additional benefit. Dual-target presurgical planning may allow intraoperative selection of the optimal target for best outcomes. DBS therapy may require long-term continuation, as device removal after 4 years in a reported case led to tremor recurrence comparable to the preimplantation state.[37](B3)
Magnetic resonance-guided focused ultrasound is an established lesioning technique for selected tremor disorders. Application in Holmes tremor remains investigational and is supported primarily by limited case-level evidence rather than randomized controlled trials.[38][39][40][41][42]
Differential Diagnosis
Several tremor disorders are included in the differential diagnosis of Holmes tremor. Essential tremor is the most common action tremor and is typically bilateral, with a frequency of 4 to 12 Hz and onset most often in the 6th to 7th decade of life. Intention tremor may overlap clinically but lacks the characteristic resting component of Holmes tremor. Parkinson disease tremor is the most common resting tremor and is typically asymmetric, with improvement during voluntary movement and absence of the combined rest, postural, and intention components seen in Holmes tremor.
Orthostatic tremor occurs in middle-aged and older adults and presents with unsteadiness on standing, with a high-frequency tremor of approximately 16 Hz predominantly in the lower extremities. Physiologic tremor is a low-amplitude, high-frequency tremor (8 to 12 Hz) that does not interfere with activities of daily living. Cerebellar tremor is typically of low frequency, usually less than 5 Hz, and is predominantly an intention tremor without a resting component. Functional tremor occurs without an identifiable structural neurologic lesion and may present with variable manifestations, including frequency variability, distractibility, and suppression with divided attention, often with poor or inconsistent response to pharmacologic therapy.[43][44][45]
Pertinent Studies and Ongoing Trials
Holmes tremor is a rare lesion-related tremor for which randomized controlled trial data are lacking. Current evidence is derived primarily from case reports, case series, systematic reviews, scoping reviews, and meta-analyses.[46]
Prognosis
Prognosis depends on the underlying lesion, tremor severity, associated neurologic deficits, and response to therapy. Pharmacologic response is variable, and medically refractory cases may improve with DBS, although benefit is often incomplete, and target selection requires individualization. Existing evidence suggests that the GPi, VOA, VOP, Vim, or combined targets may be considered, depending on the dominant tremor component and lesion anatomy.
Complications
Holmes tremor is associated with significant functional limitation and reduced quality of life. Prominent complications include impairment in activities of daily living, such as feeding, dressing, writing, and other tasks requiring coordinated motor control, often resulting in loss of independence and increased caregiver burden. Tremor frequently involves proximal musculature, further reducing mobility and functional capacity.
Complications may also arise from therapeutic interventions. Surgical management with thalamotomy carries risks that include intracerebral hemorrhage, weakness, dystonia, and speech disturbances. While often effective in refractory cases, DBS is associated with potential complications, such as intracerebral hemorrhage, weakness, hardware-related infection, and the need for ongoing device maintenance. Persistent symptoms may also contribute to psychological distress, particularly in patients with underlying neurologic injury.
Consultations
Management of Holmes tremor requires an interprofessional approach to optimize diagnosis, treatment selection, and functional outcomes. Neurology consultation is essential for diagnostic confirmation, tremor characterization, and initiation of medical therapy. Neurosurgical evaluation is indicated early in patients with medically refractory symptoms to assess candidacy for invasive interventions, such as DBS or lesioning procedures.
Physical medicine and rehabilitation specialists play a key role in functional assessment and coordination of rehabilitative strategies. Physical therapists assist with mobility, balance, and motor control, while occupational therapists focus on improving performance of activities of daily living and recommending adaptive strategies or assistive devices. Social workers provide support with care coordination, access to resources, and counseling to address the psychosocial impact of chronic neurologic impairment. Coordinated interprofessional care facilitates comprehensive management, improves quality of life, and supports patient-centered outcomes.
Deterrence and Patient Education
Holmes tremor is significantly incapacitating, with tremor present during rest, maintenance of posture, and intentional movement, in addition to deficits related to the primary lesion. No universally effective treatment exists, and management is individualized based on tremor severity, lesion location, functional impairment, and response to therapy. Pharmacologic therapy and DBS are the main treatment approaches, although outcomes are often incomplete.
Initial treatment with levetiracetam, trihexyphenidyl, or levodopa may be trialed for clinical response. Patients with disabling tremor despite adequate medication trials should be referred to a movement disorders neurologist and functional neurosurgeon for consideration of DBS or lesioning procedures. Counseling should emphasize that improvement may be partial, and preexisting neurologic deficits from the primary lesion may not improve.
Pearls and Other Issues
Key thoughts regarding Holmes tremor are as follows:
- Holmes tremor is a resting and kinetic tremor that is worsened by sustained posture, with low frequency (<4.5 Hz) and high amplitude.
- Possible etiologies include vascular, traumatic, neoplastic, infectious, neuroimmunologic, neuroinflammatory, and neurodegenerative pathologies.
- Holmes tremor is an extremely rare condition, with only 155 cases reported between 1904 and 2016.
- The pathophysiology is complex and involves disruption of interconnected motor circuits, particularly dopaminergic nigrostriatal, cerebellothalamic, and dentatorubro-olivary pathways.
- Clinical evaluation requires a thorough history, risk factor assessment, and physical examination demonstrating unilateral resting, postural, and intention tremor with low frequency and high amplitude, often with proximal predominance.
- The Fahn-Tolosa-Marin Tremor Rating Scale is used to assess tremor severity, guide the selection of medical or surgical therapy, and monitor treatment response over time.
- Differential diagnosis includes essential tremor, intention tremor, Parkinson disease tremor (most common resting tremor), orthostatic tremor, physiologic tremor, cerebellar tremor (typically low frequency, usually <5 Hz, with absent resting component), and functional tremor.
- Pharmacologic treatment options include antiepileptic agents (levetiracetam, topiramate), dopamine agonists, anticholinergics (trihexyphenidyl), benzodiazepines, and botulinum toxin injections.
- Surgical options for refractory cases include stereotactic thalamic ablation, gamma knife thalamotomy, and DBS targeting the GPi or thalamic VOP, VOA, or Vim nucleus.
- Prognosis depends on the etiology, with pharmacoresistant tremors showing variable but sometimes favorable response to DBS targeting nodes within the basal ganglia–thalamocortical circuits.
Early recognition and timely management of underlying structural lesions may help limit progression of Holmes tremor and reduce long-term disability. Interprofessional collaboration among neurology, neurosurgery, rehabilitation medicine, and allied health services is essential to optimize functional outcomes and quality of life.
Enhancing Healthcare Team Outcomes
Holmes tremor is a rare, disabling movement disorder featuring rest, postural, and intentional tremor with low frequency and high amplitude, typically caused by cerebellothalamic and dopaminergic pathway lesions. Symptom onset often occurs weeks to months after structural brain injury from conditions such as stroke, trauma, tumor formation, or demyelinating disease, contributing to frequent misdiagnosis. Clinical evaluation relies on careful neurologic examination and brain magnetic resonance imaging to identify underlying lesions. Management remains challenging and includes pharmacologic therapy, using agents such as levetiracetam, levodopa, and anticholinergics, with variable response. DBS may be considered for refractory cases, particularly targeting basal ganglia or thalamic circuits to improve tremor control and functional outcomes.
Interprofessional collaboration is essential to optimize care. Physicians and advanced practice providers lead diagnosis, treatment selection, and referral for surgical evaluation. Primary care clinicians facilitate early recognition and longitudinal management. Nursing staff monitor symptoms, treatment response, and functional status, while pharmacists guide medication selection and safety. Neurologists and neurosurgeons coordinate advanced therapies, and rehabilitation specialists support functional recovery. Shared decision-making, timely referral, and coordinated follow-up improve quality of life, reduce complications, and enhance patient-centered outcomes.
References
Kilbane C, Ramirez-Zamora A, Ryapolova-Webb E, Qasim S, Glass GA, Starr PA, Ostrem JL. Pallidal stimulation for Holmes tremor: clinical outcomes and single-unit recordings in 4 cases. Journal of neurosurgery. 2015 Jun:122(6):1306-14. doi: 10.3171/2015.2.JNS141098. Epub 2015 Mar 20 [PubMed PMID: 25794341]
Level 3 (low-level) evidenceStarr PA. Deep brain stimulation for other tremors, myoclonus, and chorea. Handbook of clinical neurology. 2013:116():209-15. doi: 10.1016/B978-0-444-53497-2.00016-4. Epub [PubMed PMID: 24112895]
Raina GB, Cersosimo MG, Folgar SS, Giugni JC, Calandra C, Paviolo JP, Tkachuk VA, Zuñiga Ramirez C, Tschopp AL, Calvo DS, Pellene LA, Uribe Roca MC, Velez M, Giannaula RJ, Fernandez Pardal MM, Micheli FE. Holmes tremor: Clinical description, lesion localization, and treatment in a series of 29 cases. Neurology. 2016 Mar 8:86(10):931-8. doi: 10.1212/WNL.0000000000002440. Epub 2016 Feb 10 [PubMed PMID: 26865524]
Level 3 (low-level) evidenceLiu ZQ, Wan ZR, Jia XT, Yang XZ, Fang XX, Zhang ZY. [Clinical features and short-term prognosis of Holmes' tremor]. Zhonghua yi xue za zhi. 2019 Mar 19:99(11):801-805. doi: 10.3760/cma.j.issn.0376-2491.2019.11.001. Epub [PubMed PMID: 30893720]
Fox MD. Mapping Symptoms to Brain Networks with the Human Connectome. The New England journal of medicine. 2018 Dec 6:379(23):2237-2245. doi: 10.1056/NEJMra1706158. Epub [PubMed PMID: 30575457]
Joutsa J, Shih LC, Fox MD. Mapping holmes tremor circuit using the human brain connectome. Annals of neurology. 2019 Dec:86(6):812-820. doi: 10.1002/ana.25618. Epub 2019 Oct 30 [PubMed PMID: 31614012]
Madelein van der Stouwe AM, Nieuwhof F, Helmich RC. Tremor pathophysiology: lessons from neuroimaging. Current opinion in neurology. 2020 Aug:33(4):474-481. doi: 10.1097/WCO.0000000000000829. Epub [PubMed PMID: 32657888]
Level 3 (low-level) evidenceDeuschl G, Bergman H. Pathophysiology of nonparkinsonian tremors. Movement disorders : official journal of the Movement Disorder Society. 2002:17 Suppl 3():S41-8 [PubMed PMID: 11948754]
Deuschl G, Raethjen J, Lindemann M, Krack P. The pathophysiology of tremor. Muscle & nerve. 2001 Jun:24(6):716-35 [PubMed PMID: 11360255]
Level 3 (low-level) evidenceAydin S, Abuzayed B, Kiziltan G, Gunduz A, Yagci S, Mengi M, Kizilkilic O, Uzan M, Hanci M. Unilateral thalamic Vim and GPi stimulation for the treatment of Holmes' tremor caused by midbrain cavernoma: case report and review of the literature. Journal of neurological surgery. Part A, Central European neurosurgery. 2013 Jul:74(4):271-6. doi: 10.1055/s-0032-1322549. Epub 2013 Jan 14 [PubMed PMID: 23319330]
Level 3 (low-level) evidenceSeidel S, Kasprian G, Leutmezer F, Prayer D, Auff E. Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor. Journal of neurology, neurosurgery, and psychiatry. 2009 Aug:80(8):921-3. doi: 10.1136/jnnp.2008.146324. Epub 2008 May 1 [PubMed PMID: 18450789]
Level 3 (low-level) evidenceFoote KD, Okun MS. Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note. Neurosurgery. 2005 Apr:56(2 Suppl):E445; discussion E445 [PubMed PMID: 15794849]
Level 3 (low-level) evidenceKrack P, Dostrovsky J, Ilinsky I, Kultas-Ilinsky K, Lenz F, Lozano A, Vitek J. Surgery of the motor thalamus: problems with the present nomenclatures. Movement disorders : official journal of the Movement Disorder Society. 2002:17 Suppl 3():S2-8 [PubMed PMID: 11948749]
Level 3 (low-level) evidenceGhika J, Bogousslavsky J, Henderson J, Maeder P, Regli F. The "jerky dystonic unsteady hand": a delayed motor syndrome in posterior thalamic infarctions. Journal of neurology. 1994 Aug:241(9):537-42 [PubMed PMID: 7799002]
Level 3 (low-level) evidenceLehéricy S, Grand S, Pollak P, Poupon F, Le Bas JF, Limousin P, Jedynak P, Marsault C, Agid Y, Vidailhet M. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology. 2001 Sep 25:57(6):1055-66 [PubMed PMID: 11571334]
Shepherd GM, Tauböll E, Bakke SJ, Nyberg-Hansen R. Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage. Movement disorders : official journal of the Movement Disorder Society. 1997 May:12(3):432-7 [PubMed PMID: 9159743]
Level 3 (low-level) evidenceBostan AC, Strick PL. The basal ganglia and the cerebellum: nodes in an integrated network. Nature reviews. Neuroscience. 2018 Jun:19(6):338-350. doi: 10.1038/s41583-018-0002-7. Epub [PubMed PMID: 29643480]
Bostan AC, Dum RP, Strick PL. The basal ganglia communicate with the cerebellum. Proceedings of the National Academy of Sciences of the United States of America. 2010 May 4:107(18):8452-6. doi: 10.1073/pnas.1000496107. Epub 2010 Apr 19 [PubMed PMID: 20404184]
Level 3 (low-level) evidenceHoshi E, Tremblay L, Féger J, Carras PL, Strick PL. The cerebellum communicates with the basal ganglia. Nature neuroscience. 2005 Nov:8(11):1491-3 [PubMed PMID: 16205719]
Level 3 (low-level) evidenceIyer RS, Wattamwar P, Thomas B. Reversible Holmes' tremor due to spontaneous intracranial hypotension. BMJ case reports. 2017 Jul 27:2017():. pii: bcr-2017-220348. doi: 10.1136/bcr-2017-220348. Epub 2017 Jul 27 [PubMed PMID: 28754752]
Level 3 (low-level) evidenceTan JH, Chan BP, Wilder-Smith EP, Ong BK. A unique case of reversible hyperglycemic Holmes' tremor. Movement disorders : official journal of the Movement Disorder Society. 2006 May:21(5):707-9 [PubMed PMID: 16416414]
Level 3 (low-level) evidencePahwa R, Lyons KL, Wilkinson SB, Carpenter MA, Tröster AI, Searl JP, Overman J, Pickering S, Koller WC. Bilateral thalamic stimulation for the treatment of essential tremor. Neurology. 1999 Oct 22:53(7):1447-50 [PubMed PMID: 10534249]
Level 1 (high-level) evidenceWang KL, Wong JK, Eisinger RS, Carbunaru S, Smith C, Hu W, Wagle Shukla A, Hess CW, Okun MS, Ramirez-Zamora A. Therapeutic Advances in the Treatment of Holmes Tremor: Systematic Review. Neuromodulation : journal of the International Neuromodulation Society. 2022 Aug:25(6):796-803. doi: 10.1111/ner.13220. Epub 2022 Feb 15 [PubMed PMID: 32578304]
Level 3 (low-level) evidenceRojas NG, Cesarini M, Etcheverry JL, Da Prat G, Viera Aramburu T, Gatto EM. Holmes Tremor Partially Responsive to Topiramate: A Case Report. Tremor and other hyperkinetic movements (New York, N.Y.). 2018:8():565. doi: 10.7916/D82C0FFN. Epub 2018 Jun 26 [PubMed PMID: 30191084]
Level 3 (low-level) evidenceAlqwaifly M. Treatment responsive Holmes tremor: case report and literature review. International journal of health sciences. 2016 Oct:10(4):558-562 [PubMed PMID: 27833521]
Level 3 (low-level) evidenceKreisler A, Bouchain B, Defebvre L, Krystkowiak P. Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor. Tremor and other hyperkinetic movements (New York, N.Y.). 2019:9():. doi: 10.7916/tohm.v0.640. Epub 2019 Jul 26 [PubMed PMID: 31413896]
Level 2 (mid-level) evidenceKrauss JK, Mohadjer M, Nobbe F, Mundinger F. The treatment of posttraumatic tremor by stereotactic surgery. Symptomatic and functional outcome in a series of 35 patients. Journal of neurosurgery. 1994 May:80(5):810-9 [PubMed PMID: 8169619]
Kim MC, Son BC, Miyagi Y, Kang JK. Vim thalamotomy for Holmes' tremor secondary to midbrain tumour. Journal of neurology, neurosurgery, and psychiatry. 2002 Oct:73(4):453-5 [PubMed PMID: 12235320]
Level 3 (low-level) evidenceMaki F, Sato S, Watanabe K, Yanagisawa T, Hagiwara Y, Shimizu T, Hasegawa Y. Vim thalamotomy in a patient with Holmes' tremor and palatal tremor - Pathophysiological considerations. BMC neurology. 2015 Mar 11:15():26. doi: 10.1186/s12883-015-0277-5. Epub 2015 Mar 11 [PubMed PMID: 25879699]
Tripathi M, Mehta S, Singla R, Ahuja CK, Tandalya N, Tuleasca C, Batish A, Mohindra S, Agrahari A, Kaur R. Vim stereotactic radiosurgical thalamotomy for drug-resistant idiopathic Holmes tremor: a case report. Acta neurochirurgica. 2021 Jul:163(7):1867-1871. doi: 10.1007/s00701-020-04489-1. Epub 2020 Jul 17 [PubMed PMID: 32676689]
Level 3 (low-level) evidenceArtusi CA, Farooqi A, Romagnolo A, Marsili L, Balestrino R, Sokol LL, Wang LL, Zibetti M, Duker AP, Mandybur GT, Lopiano L, Merola A. Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming. Journal of neurology. 2018 Nov:265(11):2473-2493. doi: 10.1007/s00415-018-8823-x. Epub 2018 Mar 6 [PubMed PMID: 29511865]
Level 2 (mid-level) evidenceEspinoza Martinez JA, Arango GJ, Fonoff ET, Reithmeier T, Escobar OA, Furlanetti L, Alvarez Berastegui GR, Fernandes da Silva FE, Contreras Lopez WO. Deep brain stimulation of the globus pallidus internus or ventralis intermedius nucleus of thalamus for Holmes tremor. Neurosurgical review. 2015 Oct:38(4):753-63. doi: 10.1007/s10143-015-0636-0. Epub 2015 May 20 [PubMed PMID: 25990341]
Martinez V, Hu SC, Foutz TJ, Ko A. Successful Treatment of Holmes Tremor With Deep Brain Stimulation of the Prelemniscal Radiations. Frontiers in surgery. 2018:5():21. doi: 10.3389/fsurg.2018.00021. Epub 2018 May 31 [PubMed PMID: 29904635]
Dec-Ćwiek M, Tutaj M, Pietraszko W, Libionka W, Krupa M, Moskała M, Rudzińska-Bar M, Słowik A, Pera J. Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Refractory Holmes Tremor. Stereotactic and functional neurosurgery. 2019:97(3):183-188. doi: 10.1159/000502563. Epub 2019 Oct 10 [PubMed PMID: 31600751]
Plaha P, Khan S, Gill SS. Bilateral stimulation of the caudal zona incerta nucleus for tremor control. Journal of neurology, neurosurgery, and psychiatry. 2008 May:79(5):504-13 [PubMed PMID: 18037630]
Romanelli P, Brontë-Stewart H, Courtney T, Heit G. Possible necessity for deep brain stimulation of both the ventralis intermedius and subthalamic nuclei to resolve Holmes tremor. Case report. Journal of neurosurgery. 2003 Sep:99(3):566-71 [PubMed PMID: 12959446]
Level 3 (low-level) evidenceGrabska N, Rudzińska M, Dec-Ćwiek M, Tutaj M, Pietraszko W, Michalski M, Szczudlik A. Deep brain stimulation in the treatment of Holmes tremor - a long-term case observation. Neurologia i neurochirurgia polska. 2014:48(4):292-5. doi: 10.1016/j.pjnns.2014.06.002. Epub 2014 Jun 27 [PubMed PMID: 25168330]
Level 3 (low-level) evidenceWalters H, Shah BB. Focused Ultrasound and Other Lesioning Therapies in Movement Disorders. Current neurology and neuroscience reports. 2019 Aug 3:19(9):66. doi: 10.1007/s11910-019-0975-2. Epub 2019 Aug 3 [PubMed PMID: 31377876]
Fishman PS, Frenkel V. Treatment of Movement Disorders With Focused Ultrasound. Journal of central nervous system disease. 2017:9():1179573517705670. doi: 10.1177/1179573517705670. Epub 2017 Jun 6 [PubMed PMID: 28615985]
Meng Y, Pople CB, Kalia SK, Kalia LV, Davidson B, Bigioni L, Li DZ, Suppiah S, Mithani K, Scantlebury N, Schwartz ML, Hamani C, Lipsman N. Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson's disease. Journal of neurosurgery. 2021 Jul 1:135(1):273-278. doi: 10.3171/2020.5.JNS20692. Epub 2020 Aug 7 [PubMed PMID: 32764177]
Paff M, Boutet A, Neudorfer C, Elias GJB, Germann J, Loh A, Kucharczyk W, Fasano A, Schwartz ML, Lozano AM. Magnetic Resonance-Guided Focused Ultrasound Thalamotomy to Treat Essential Tremor in Nonagenarians. Stereotactic and functional neurosurgery. 2020:98(3):182-186. doi: 10.1159/000506817. Epub 2020 Mar 30 [PubMed PMID: 32224617]
Pineda-Pardo JA, Urso D, Martínez-Fernández R, Rodríguez-Rojas R, Del-Alamo M, Millar Vernetti P, Máñez-Miró JU, Hernández-Fernández F, de Luis-Pastor E, Vela-Desojo L, Obeso JA. Transcranial Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor: A Comprehensive Lesion Characterization. Neurosurgery. 2020 Aug 1:87(2):256-265. doi: 10.1093/neuros/nyz395. Epub [PubMed PMID: 31574145]
Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgraduate medical journal. 2005 Dec:81(962):756-62 [PubMed PMID: 16344298]
Bötzel K, Tronnier V, Gasser T. The differential diagnosis and treatment of tremor. Deutsches Arzteblatt international. 2014 Mar 28:111(13):225-35; quiz 236. doi: 10.3238/arztebl.2014.0225. Epub [PubMed PMID: 24739887]
Gironell A. Holmes' tremor or functional tremor: Neurophysiological criteria can help diagnosis. Clinical neurophysiology practice. 2019:4():9-10. doi: 10.1016/j.cnp.2018.11.003. Epub 2019 Jan 25 [PubMed PMID: 30793067]
Mendonça MD, Meira B, Fernandes M, Barbosa R, Bugalho P. Deep brain stimulation for lesion-related tremors: A systematic review and meta-analysis. Parkinsonism & related disorders. 2018 Feb:47():8-14. doi: 10.1016/j.parkreldis.2017.12.014. Epub 2017 Dec 13 [PubMed PMID: 29249682]
Level 1 (high-level) evidence